A public-private consortium in Israel will collect samples and sequence genomes from thousands of COVID-19 patients in an effort to identify protective and risk-bearing genetic factors with the hopes of discovering new diagnostic and treatment methods.

This article has been updated from a previous version to include additional information about the saliva collection device specified in the EUA summary.

Lawmakers on Thursday called on the US Food and Drug Administration to provide information about the accuracy of the various SARS-CoV-2 diagnostics being used in response to the ongoing pandemic.

Prompted in part by the COVID-19 pandemic, the T.H. Chan School of Public Health at Harvard University

African genomics research company 54gene said on Tuesday that it has closed a $15 million Series A financing round.

A multi-omic analysis of high-grade serous ovarian cancer has uncovered molecular differences between clinical subgroups of the disease.

The US Food and Drug Administration on Monday granted Emergency Use Authorization to two lab-developed real-time RT-PCR tests for SARS-CoV-2, the virus that causes coronavirus disease COVID-19.

Illumina reported after the close of the market on Tuesday preliminary first quarter revenues of approximately $858 million. The firm also withdrew its full-year revenue guidance due to disruption from the COVID-19 pandemic.

Fluidigm said after the close of the market on Tuesday that it expects Q1 revenues of approximately $27.6 million.

A new research portal from software developer Nference and Johnson & Johnson's Janssen Pharmaceutica has identified several new expression mechanisms for COVID-19 and the novel SARS-CoV-2 coronavirus that causes the deadly disease.

The National Institutes of Health have started recruiting for a new study that aims to determine how many adults in the US who have not had a confirmed infection with SARS-CoV-2 carry antibodies to the virus, indicating that they were previously infected.

From a purple dot in Wuhan, China, lines start to emerge, reaching the UK, Thailand, and Australia.

LexaGene, which has developed a pathogen detection platform for the veterinary and food safety sectors, is now pivoting to clinical diagnostics by modifying its LX Analyzer platform for viruses

A team led by researchers at St. Jude Children's Research Hospital, the European Molecular Biology Laboratory

Dr. Nefertiti Brown, who is an attending physician in California, was tested for COVID-19 on March 18th after displaying symptoms of the virus.